Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Hidradenitis suppurativa tunnels worsen the disease and often need surgery because current treatments are not very effective.

The new composite scaffold may effectively treat chronic and deep wounds.

Early diagnosis and a multidisciplinary approach are crucial for children with Trichothiodystrophy and hidden learning disorders.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Hyperbaric oxygen therapy speeds up recovery and improves outcomes in hair transplants.

Combining radiofrequency and ultrasound significantly boosts skin's natural hyaluronic acid production.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib treatment for hair loss may worsen acne.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Early surgery and quitting smoking can help manage hidradenitis suppurativa.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.